DHPS
Basic information
Region (hg38): 19:12675717-12681880
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with seizures and speech and walking impairment (Limited), mode of inheritance: AR
- neurodevelopmental disorder with seizures and speech and walking impairment (Moderate), mode of inheritance: AR
- neurodevelopmental disorder with seizures and speech and walking impairment (Strong), mode of inheritance: AR
- neurodevelopmental disorder with seizures and speech and walking impairment (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodevelopmental disorder with seizures and speech and walking impairment | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 30661771 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (43 variants)
- not_provided (19 variants)
- DHPS-related_disorder (10 variants)
- Neurodevelopmental_disorder_with_seizures_and_speech_and_walking_impairment (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DHPS gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001930.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | |||||
| missense | 44 | 46 | ||||
| nonsense | 1 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 1 | 4 | 46 | 9 | 3 |
Highest pathogenic variant AF is 0.00033649377
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DHPS | protein_coding | protein_coding | ENST00000210060 | 9 | 6186 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000163 | 0.972 | 125598 | 0 | 150 | 125748 | 0.000597 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.393 | 249 | 232 | 1.07 | 0.0000139 | 2423 |
| Missense in Polyphen | 85 | 101.98 | 0.8335 | 1082 | ||
| Synonymous | -0.783 | 112 | 102 | 1.10 | 0.00000684 | 738 |
| Loss of Function | 1.96 | 9 | 18.0 | 0.500 | 8.60e-7 | 197 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000681 | 0.000680 |
| Ashkenazi Jewish | 0.00140 | 0.00139 |
| East Asian | 0.000272 | 0.000272 |
| Finnish | 0.000509 | 0.000508 |
| European (Non-Finnish) | 0.000680 | 0.000677 |
| Middle Eastern | 0.000272 | 0.000272 |
| South Asian | 0.000655 | 0.000653 |
| Other | 0.000654 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the NAD-dependent oxidative cleavage of spermidine and the subsequent transfer of the butylamine moiety of spermidine to the epsilon-amino group of a critical lysine residue of the eIF-5A precursor protein to form the intermediate deoxyhypusine residue. This is the first step of the post- translational modification of that lysine into an unusual amino acid residue named hypusine. Hypusination is unique to mature eIF- 5A factor and is essential for its function.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;hypusine biosynthesis;Hypusine synthesis from eIF5A-lysine
(Consensus)
Recessive Scores
- pRec
- 0.164
Intolerance Scores
- loftool
- 0.918
- rvis_EVS
- -0.53
- rvis_percentile_EVS
- 20.7
Haploinsufficiency Scores
- pHI
- 0.267
- hipred
- N
- hipred_score
- 0.429
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.923
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dhps
- Phenotype
- immune system phenotype; renal/urinary system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- dhps
- Affected structure
- primary islet
- Phenotype tag
- abnormal
- Phenotype quality
- has fewer parts of type
Gene ontology
- Biological process
- translation;spermidine metabolic process;positive regulation of cell population proliferation;peptidyl-lysine modification to peptidyl-hypusine
- Cellular component
- cytoplasm;cytosol
- Molecular function
- protein binding;deoxyhypusine synthase activity;identical protein binding